Search Browse Earnings

Bioventus Inc. — SlamSEC

Bioventus Inc.

Nasdaq:BVS

Surgical & Medical Instruments & Apparatus·DURHAM, NC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$512.3M

+0.0% YoY

FY 2025

Adj. EBITDA

-$24.4M

-4.8% margin

FY 2025

Net Income

-$156.2M

-30.5% margin

FY 2025

EPS (Diluted)

-$2.49

FY 2025

Stock Price

$8.41

-7.5%

2026-03-06

52W Range

$5.81 – $11.25

P/E Ratio

-3.4x

Market Cap

—

Cash

$41.6M

FY 2025

Total Debt

$308.3M

FY 2025

Net Debt

$266.7M

FY 2025

Enterprise Value

—

Debt / EBITDA

-10.9x

FY 2025

EV / EBITDA

—

Employees

—

CEO

Claypoole Robert E

CFO

Singleton Mark Leonard